$2,938.60 consulting Payment -- Amgen Inc to Dr. Kevin Hill

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Amgen Inc made a $2.9K consulting payment to Kevin Hill, a Cardiology specialist in Toledo, OH. The payment of $2938.60 was made by Amgen Inc. to Dr. Kevin Hill for consulting services. The payment was made on February 8, 2026, indicating a recent engagement. Dr. Hill's specialty is Cardiology, and the payment was for consulting fees.

Patient Guidance: What This Payment Means for You

This payment to your cardiologist was for consulting services and is publicly available information. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

This consulting fee payment to a cardiologist is within the moderate range compared to similar payments in the specialty.

Regulatory Context: Sunshine Act Requirements

This payment is reported under the Physician Payments Sunshine Act, part of the Affordable Care Act, requiring transparency in financial relationships between drug manufacturers and healthcare providers.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharmaceutical-payments
• consulting-fees
• cardiology
• physician-payments
• open-payments-data
• amgen-inc

Understanding consulting Payments

Consulting payments are made when pharmaceutical companies hire physicians as advisors or consultants. This can include serving on advisory boards, providing expert medical opinions on drug development or marketing strategies, and reviewing clinical data. Consulting is one of the most common forms of pharmaceutical payment to physicians and can range from a few hundred dollars for a brief consultation to tens of thousands of dollars for ongoing advisory relationships.

Frequently Asked Questions About This Payment

What was this $2.9K payment for?

This was a consulting payment of $2.9K from Amgen Inc to Kevin Hill, categorized as "Consulting Fee". The payment was reported under the Sunshine Act (CMS Open Payments).

Does Kevin Hill accept pharmaceutical money?

Yes, Kevin Hill received this $2.9K payment from Amgen Inc. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Kevin Hill's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this consulting payment?

A consulting payment of $2.9K may reflect legitimate advisory services the physician provides. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Cardiology?

To compare this payment against Cardiology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Cardiology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Kevin Hill's relationship with Amgen Inc?

The payment amount falls within a moderate range for consulting fees. This $2.9K consulting payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Cardiology?

The payment was made by a major pharmaceutical company, Amgen Inc.

What should patients do after learning about this payment?

This payment to your cardiologist was for consulting services and is publicly available information.

What else should I know about this consulting payment?

The date of payment is in the future, suggesting a planned engagement.

Related Reports

• View Dr. Kevin Hill's full payment report
• Amgen Inc full spending report
• Browse all Cardiology payments
• Browse all payments in Ohio
• Search for other payments